Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Clinical trial NCT01065441 · COMPLETED

Trial details

NCT number: NCT01065441
Sponsor: Michael Har-Noy
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors Stage II, Stage III and Stage IV Breast Cancer Colorectal Cancer Prostate Cancer Melanoma Ovarian Cancer Sarcoma Non-small Cell Lung Cancer

Start date: 2010-12-01
Primary completion: 2012-12-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.